TY  - JOUR 
AU  - Muñoz García, Delicia
AU  - Dapena Bolaño, Dolores
AU  - Pego Reigosa, Robustiano
PY  - 2013
SN  - 1471-2377
UR  - http://hdl.handle.net/20.500.11940/1864
LA  - eng
TI  - Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
DO  - 10.1186/1471-2377-13-82.
T2  - BMC Neurology
M2  - .
VL  - 13
ER  -